- All Companies
- Health Care
- Biotechnology
- BeiGene
BeiGene (BGNE) worth $2,775,257,761,884,882,400 Tril (up $5,273,052,522,016,078 Tril), more valuable than SBA Communications BeiGene (BGNE) worth $2,755,169,942,753,392,100 Tril (down $-5,900,796,869,874,974 Tril), still more valuable than Kimco Realty BeiGene (BGNE) worth $2,476,451,452,303,972,400 Tril (down $-487,757,358,286,485,500 Tril), still more valuable than Axon Enterprise BeiGene (BGNE) worth $2,476,451,452,303,972,400 Tril (down $-528,937,387,506,039,550 Tril), still more valuable than Axon Enterprise BeiGene (BGNE) worth $2,476,451,452,303,972,400 Tril (down $-541,743,372,202,364,670 Tril), still more valuable than Globe Life BeiGene (BGNE) worth $2,476,451,452,303,972,400 Tril (down $-479,345,584,025,174,400 Tril), still more valuable than Southern BeiGene (BGNE) worth $2,476,451,452,303,972,400 Tril (down $-574,637,176,030,178,940 Tril), still more valuable than Hewlett Packard Enterprise BeiGene (BGNE) worth $2,476,451,452,303,972,400 Tril (down $-456,370,140,893,532,860 Tril), still more valuable than Verizon Communications BeiGene (BGNE) worth $2,476,451,452,303,972,400 Tril (down $-423,476,337,065,718,590 Tril), still more valuable than Verizon Communications BeiGene (BGNE) worth $2,476,451,452,303,972,400 Tril (down $-342,246,218,452,756,350 Tril), still more valuable than Verizon Communications 